Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen

Allogeneic haematopoietic stem cell transplantation (HSCT) is the only available curative therapy for patients with thalassaemia major. With the progress in human leucocyte antigen (HLA) antigen typing technology and supportive care, the outcomes of thalassaemia major have greatly improved in recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qixin, Wu, Bingyi, Lan, Hekui, Meng, Fanyi, Ma, Xiaoxiao, Chen, Xinxin, Huang, Zhiwei, Yao, Qianqian, Xu, Jianhui, Huang, Yuxian, Wu, Shaojie, Zhu, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120500/
https://www.ncbi.nlm.nih.gov/pubmed/29962035
http://dx.doi.org/10.1111/bjh.15438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120500/
https://www.ncbi.nlm.nih.gov/pubmed/29962035
http://dx.doi.org/10.1111/bjh.15438

Ejemplares similares